Lycedep-Plus Tablet contains Clonazepam 0.5mg and Escitalopram Oxalate 10mg, combining the therapeutic effects of a benzodiazepine and a selective serotonin reuptake inhibitor (SSRI). Clonazepam acts as an anticonvulsant and anxiolytic agent by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, providing relief from anxiety, panic disorders, and seizure activity. Escitalopram Oxalate, a highly selective SSRI, increases serotonin levels in the synaptic cleft by inhibiting its reuptake, thereby improving mood and alleviating symptoms of depression and generalized anxiety disorder. Lycedep-Plus is indicated for the management of anxiety disorders, panic attacks, and depressive episodes where combined anxiolytic and antidepressant effects are desired. The combination therapy allows for synergistic action, providing rapid symptomatic relief while addressing underlying mood disturbances. Dosage should be individualized based on patient response and tolerability, with careful monitoring for potential side effects such as sedation, dizziness, gastrointestinal disturbances, and serotonin syndrome. Caution is advised in patients with a history of substance abuse, hepatic or renal impairment, and when used concomitantly with other central nervous system depressants. Lycedep-Plus should be prescribed and administered under strict medical supervision to ensure safety and efficacy.